Smith, K.H.; Trovillion, E.M.; McKinney, K.Q.; Gourabathini, P.; Wells, K.; Gandra, D.; Sholler, C.; Votruba, I.; Oesterheld, J.; Saulnier Sholler, G.L.
In Vitro and In Vivo Efficacy of Romidepsin Alone and in Addition to Standard of Care for Treatment of Ewing Sarcoma. Cancers 2025, 17, 4018.
https://doi.org/10.3390/cancers17244018
AMA Style
Smith KH, Trovillion EM, McKinney KQ, Gourabathini P, Wells K, Gandra D, Sholler C, Votruba I, Oesterheld J, Saulnier Sholler GL.
In Vitro and In Vivo Efficacy of Romidepsin Alone and in Addition to Standard of Care for Treatment of Ewing Sarcoma. Cancers. 2025; 17(24):4018.
https://doi.org/10.3390/cancers17244018
Chicago/Turabian Style
Smith, Kaitlyn H., Erin M. Trovillion, Kimberly Q. McKinney, Poornima Gourabathini, Kenzie Wells, Divya Gandra, Chloe Sholler, Ingrid Votruba, Javier Oesterheld, and Giselle L. Saulnier Sholler.
2025. "In Vitro and In Vivo Efficacy of Romidepsin Alone and in Addition to Standard of Care for Treatment of Ewing Sarcoma" Cancers 17, no. 24: 4018.
https://doi.org/10.3390/cancers17244018
APA Style
Smith, K. H., Trovillion, E. M., McKinney, K. Q., Gourabathini, P., Wells, K., Gandra, D., Sholler, C., Votruba, I., Oesterheld, J., & Saulnier Sholler, G. L.
(2025). In Vitro and In Vivo Efficacy of Romidepsin Alone and in Addition to Standard of Care for Treatment of Ewing Sarcoma. Cancers, 17(24), 4018.
https://doi.org/10.3390/cancers17244018
